Joyn Bio, founded in 2017, is a pioneering partnership forged between Bayer and Ginkgo Bioworks, specializing in the development of plant probiotics aimed at addressing critical challenges in agriculture. The company is at the forefront of engineering microbes to fulfill cereal crops' nitrogen requirements, significantly reducing reliance on synthetic nitrogen fertilizers and tackling pressing environmental concerns.
Leveraging a team of experts in microbiology, synthetic biology, plant science, and ecology, Joyn Bio is strategically positioned with its main operations centered in Boston, Massachusetts, and its state-of-the-art plant research facility located in West Sacramento, California. This unique collaboration seeks to revolutionize practices within the Agriculture, Biotechnology, and Health Care sectors.
The company received a substantial $100.00M Series A investment on March 20, 2018, backed by industry leaders such as Ginkgo Bioworks, Leaps by Bayer, and Viking Global Investors, demonstrating a strong vote of confidence in its innovative mission.
